Technical Guide

How to Build a Clinical AI Performance Dashboard: Metrics Guide

Combine clinical accuracy and drift metrics with AI runtime governance signals in one operational view, joined by a shared case or session identifier and retained to meet HIPAA and FDA post-market monitoring expectations.

Request a Demo Explore Runtime Governance

A clinical AI performance dashboard should combine clinical accuracy and drift metrics with AI runtime governance signals, including agent identity, tool-call activity, and policy enforcement events, joined by a common case or session identifier and retained in line with HIPAA and FDA post-market monitoring expectations.

What a Clinical AI Performance Dashboard Measures

A clinical AI performance dashboard is a monitoring system that brings clinical accuracy and safety metrics together with AI runtime governance and security telemetry in a single operational view. Most healthcare organizations currently build these two capabilities separately. Clinical and quality teams track sensitivity, specificity, and outcome drift. Security or platform teams, where they exist at all, monitor agent identity, tool-call activity, and policy enforcement in a different system.

This separation creates blind spots. A model can maintain acceptable clinical accuracy while an agent still acts outside its intended scope, invokes an unauthorized tool, or accesses data beyond its permission boundary. NIST's AI Risk Management Framework structures this problem into four functions: Govern, Map, Measure, and Manage. FDA's total product lifecycle approach to AI-enabled medical devices expects continuous real-world performance monitoring after deployment, not only at initial clearance. A dashboard that treats runtime governance as a first-class input, alongside clinical metrics, is a practical way to operationalize both expectations rather than bolting security monitoring onto a clinical dashboard as an afterthought.

Dashboard Components at a Glance

Four layers form the core of a clinical AI performance dashboard. Each contributes a distinct metric stream; together they give operators a complete picture of accuracy, agency, and accountability.

Clinical Metrics

Accuracy, sensitivity/specificity, and calibration drift measured against pre-specified thresholds.

Runtime Telemetry

Agent identity, tool-call activity, and policy enforcement events captured as structured signals.

Audit Layer

Immutable logging aligned to HIPAA audit control requirements under 45 CFR 164.312(b).

Governance View

Structured signals mapped to NIST AI RMF's four functions: Govern, Map, Measure, and Manage.

Architecting Runtime Governance Signals Into the Dashboard

Runtime governance signals are not a security add-on to a clinical dashboard. They are metrics in their own right. Agent identity establishes which agent, model version, and configuration produced a given action, which matters when investigating an anomalous clinical output. Tool-call activity records what external systems or functions an agent invoked during a case, and at what permission level. Policy enforcement events capture blocks, escalations, and human overrides as distinct, timestamped occurrences.

OWASP's guidance on large language model applications identifies excessive agency and insufficient tool permission scoping as a specific risk category for agentic systems, which is why tool-call activity should be monitored as its own metric stream rather than inferred from clinical outcomes after the fact. Dashboards should expose out-of-scope or excessive tool use as a near-real-time signal, not only as a retrospective audit finding. This requires event schemas for policy decisions that are distinct from clinical accuracy schemas, even though both feed the same operational view.

Two Linked Data Planes: Clinical Outcomes and Runtime Telemetry

Clinical outcome data and AI agent runtime telemetry typically originate from different systems and have different sensitivity profiles. The practical architecture keeps them as separate data planes joined by a shared identifier, rather than merging them into one undifferentiated event stream.

Keep clinical outcomes and runtime telemetry separate

Source systems, ownership, and sensitivity profiles differ. Treat each plane independently so schema changes, retention rules, and access controls can evolve without coupling the two streams.
Join on a shared case or session identifier

Link records with a common case or session ID so operators can reconstruct what the agent did alongside what the clinical outcome was, without collapsing both planes into a single event type.
Present both streams in one operational view

Surface clinical accuracy, drift, agent identity, tool calls, and policy events side by side so scope violations and accuracy regressions can be investigated together.

Implementation Decisions to Resolve Before Building the Pipeline

Before wiring clinical and governance feeds into a shared dashboard, resolve how identifiers are assigned, which event schemas each plane uses, who can access each stream, and how long records are retained. Pre-specifying these decisions reduces rework when FDA post-market expectations or internal audit reviews demand consistent, versioned metric definitions.

Core metric categories to include

Plan for clinical accuracy and drift metrics; agent identity and configuration; tool-call activity and permission level; and policy enforcement events (blocks, escalations, and human overrides). Each category should map to a stable schema so definitions remain comparable over time.

Compliance and Audit Requirements That Shape Metric Retention

Retention, review cadence, and metric versioning are shaped by HIPAA audit controls and FDA lifecycle guidance. The following requirements should influence how the dashboard stores and surfaces data.

Log agent tool calls and policy decisions as immutable, structured records to satisfy HIPAA's audit control requirement under 45 CFR 164.312(b).
Support regular review of activity logs, as required under 45 CFR 164.308(a)(1)(ii)(D), rather than storing logs without a review workflow.
Pre-specify clinical performance metrics and monitoring thresholds in advance, consistent with FDA's Predetermined Change Control Plan framework.
Differentiate monitoring cadence between pre-market baseline performance and post-market real-world performance, per FDA's SaMD Action Plan.
Set retention periods for governance and audit logs that align with organizational HIPAA documentation practices and anticipated FDA recordkeeping expectations.
Treat metric definitions as versioned artifacts, since FDA's AI lifecycle guidance and NIST's generative AI profile are both still evolving.